title: Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody.
authors.affiliation: Medizinische Klinik III, Universitat Heidelberg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Bode
authors.forename: M
authors.initials: M
authors.lastname: Runge
authors.forename: T
authors.initials: T
authors.lastname: Eberle
authors.forename: M
authors.initials: M
authors.lastname: Freitag
authors.forename: W
authors.initials: W
authors.lastname: Kübler
authors.forename: E
authors.initials: E
authors.lastname: Haber
mesh_terms: D000818:Animals; D005337:Fibrin / Q000276:immunology; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage; D066298:In Vitro Techniques; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000494:pharmacology*; D011817:Rabbits; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D005337:Fibrin; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator